ELIXINOL TO ACQUIRE CANNACARE HEALTH CALL Transcript
Good morning, everybody, and welcome to Elixinol Global's special investor briefing. My name is Juliana Roadley, and I'm an Account Director at the IR Department. It is a pleasure to be supporting Elixinol with Investor Relations through this exciting time. Presenting today will be Oliver Horn, the Global Chief Executive and Executive Directing Officer; and also Ron Dufficy, who is the Chief Financial Officer to discuss Elixinol's signing of a binding agreement to acquire CannaCare.
Now the formal part of the session will be followed by Q&A. If you would like to ask a question, we would ask that you keep those questions until the end of the briefing. And if you type them into the space below, in the band at the bottom of the screen, and we'll be able to answer those questions for you. Just to let you know that this session will be recorded today, and the recording will be available online on the Elixinol website after the event.
Now, I'd like to hand over to the CEO, Oliver Horn. Thank you, Oliver.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |